While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a ...

A new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...

OZEMPIC-PENIS sounds like a sexually transmitted disease you really wouldn’t want to catch. But it’s actually a term that has ...

Ram Kapoor defended the use of Ozempic for weight loss, emphasising that it requires a doctor's prescription. He criticised ...

Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

What if we told you that scientists are currently testing a new weight-loss drug that’s similar to Ozempic but sans the scary ...

Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE ...